Yanyan Chang serves as the Vice President of Communications for Sanofi's Diabetes and Cardiovascular division, where she leverages her extensive background in public relations and corporate communications to shape the narrative around flagship brands and drive strategic initiatives. With a robust portfolio of responsibilities totaling...
Yanyan Chang serves as the Vice President of Communications for Sanofi's Diabetes and Cardiovascular division, where she leverages her extensive background in public relations and corporate communications to shape the narrative around flagship brands and drive strategic initiatives. With a robust portfolio of responsibilities totaling €7 billion, Yanyan is instrumental in developing and implementing comprehensive communications strategies that resonate both externally and internally. Her expertise is particularly evident in orchestrating product launches and profiling Sanofi's business strategy in a highly competitive landscape, ensuring that the company's innovative solutions are effectively communicated to stakeholders.
In her role, Yanyan focuses on thought leadership communications that highlight disruptive innovations and the evolving healthcare model, positioning Sanofi as a pioneer in the industry. She adeptly navigates the complexities of marketing communications and public affairs across diverse markets, including Europe, the US, and China, drawing on her long-standing experience to foster strong relationships with key opinion leaders and media outlets. Yanyan's leadership in product communications not only enhances brand visibility but also cultivates trust and engagement among healthcare professionals and patients alike.
Her skill set encompasses a wide range of areas, including corporate communications, product marketing, and strategic public relations, allowing her to craft compelling narratives that align with Sanofi's mission to transform patient care. As a visionary leader, Yanyan Chang is committed to advancing the dialogue around diabetes and cardiovascular health, ensuring that Sanofi remains at the forefront of innovation and patient-centric solutions in the global healthcare landscape.
